Acute antidepressant response to sleep deprivation combined with light therapy is influenced by the catechol-O-methyltransferase Val(108/158)Met polymorphism

Journal of Affective Disorders

Volumn 121, Issue 1-2, 2010, Pages 68-72

  Benedetti, Francesco ^a   Barbini, Barbara ^a   Bernasconi, Alessandro ^a   Fulgosi, Mara Cigala ^a   Dallaspezia, Sara ^a   Gavinelli, Chiara ^a   Locatelli, Clara ^a   Lorenzi, Cristina ^a   Pirovano, Adele ^a   Radaelli, Daniele ^a   Smeraldi, Enrico ^a   Colombo, Cristina ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Bipolar disorder; COMT; Dopamine; Light therapy; Major depression; Norepinephrine; Sleep deprivation

Indexed keywords

CATECHOL METHYLTRANSFERASE;

ADULT; ARTICLE; BIPOLAR DEPRESSION; FEMALE; GENETIC POLYMORPHISM; HETEROZYGOSITY; HOMOZYGOSITY; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PHOTOTHERAPY; PRIORITY JOURNAL; SLEEP DEPRIVATION; WAKEFULNESS;

ADULT; ALLELES; BIPOLAR DISORDER; CATECHOL O-METHYLTRANSFERASE; COMBINED MODALITY THERAPY; FEMALE; GENOTYPE; HETEROZYGOTE DETECTION; HOMOZYGOTE; HUMANS; MALE; MIDDLE AGED; PHOTOTHERAPY; POLYMORPHISM, GENETIC; SLEEP DEPRIVATION; TREATMENT OUTCOME;

EID: 72449150176     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2009.05.017     Document Type: Article

References (38)

1. Amin M.M., Khalid R., and Khan P. Relationship between sleep deprivation and urinary MHPG levels. Int. Pharmacopsychiatry 15 (1980) 81-85
2. Arias B., Serretti A., Lorenzi C., Gasto C., Catalan R., and Fananas L. Analysis of COMT gene (Val 158 Met polymorphism) in the clinical response to SSRIs in depressive patients of European origin. J. Affect. Disord. 90 (2006) 251-256
3. Baune B.T., Hohoff C., Berger K., Neumann A., Mortensen S., Roehrs T., Deckert J., Arolt V., and Domschke K. Association of the COMT val158met variant with antidepressant treatment response in major depression. Neuropsychopharmacology 33 (2008) 924-932
4. Benedetti F., and Smeraldi E. Neuroimaging and genetics of antidepressant response to sleep deprivation: implications for drug development. Current Pharmaceutical Design 15 22 (2009) 2637-2649
5. Benedetti F., Barbini B., Lucca A., Campori E., Colombo C., and Smeraldi E. Sleep deprivation hastens the antidepressant action of fluoxetine. Eur. Arch. Psychiatry Clin. Neurosci. 247 (1997) 100-103
6. Benedetti F., Serretti A., Colombo C., Campori E., Barbini B., Di Bella D., and Smeraldi E. Influence of a functional polymorphism within the promoter of the serotonin transporter gene on the effects of total sleep deprivation in bipolar depression. Am. J. Psychiatr. 156 (1999) 1450-1452
7. Benedetti F., Campori E., Barbini B., Fulgosi M.C., and Colombo C. Dopaminergic augmentation of sleep deprivation effects in bipolar depression. Psychiatry Res. 104 (2001) 239-246
8. Benedetti F., Colombo C., Serretti A., Lorenzi C., Pontiggia A., Barbini B., and Smeraldi E. Antidepressant effects of light therapy combined with sleep deprivation are influenced by a functional polymorphism within the promoter of the serotonin transporter gene. Biol. Psychiatry 54 (2003) 687-692
9. Benedetti F., Serretti A., Colombo C., Lilli R., Lorenzi C., and Smeraldi E. Dopamine receptor D2 and D3 gene variants are not associated with the antidepressant effect of total sleep deprivation in bipolar depression. Psychiatry Res. 118 (2003) 241-247
10. Benedetti F., Barbini B., Colombo C., and Smeraldi E. Chronotherapeutics in a psychiatric ward. Sleep Med. Rev. 11 (2007) 509-522
11. Benedetti F., Bernasconi A., Blasi V., Cadioli M., Colombo C., Falini A., Lorenzi C., Radaelli D., Scotti G., and Smeraldi E. Neural and genetic correlates of antidepressant response to sleep deprivation: a fMRI study of moral valence decision in bipolar depression. Arch. Gen. Psychiatry 64 (2007) 179-187
12. Benedetti F., Barbini B., Bernasconi A., Fulgosi M.C., Colombo C., Dallaspezia S., Gavinelli C., Marino E., Pirovano A., Radaelli D., and Smeraldi E. Serotonin 5-HT(2A) receptor gene variants influence antidepressant response to repeated total sleep deprivation in bipolar depression. Prog. Neuro-psychopharmacol. Biol. Psychiatry 32 (2008) 1863-1866
13. Benedetti F., Colombo C., Pirovano A., Marino E., and Smeraldi E. The catechol-O-methyltransferase Val(108/158)Met polymorphism affects antidepressant response to paroxetine in a naturalistic setting. Psychopharmacology (Berl.) 203 (2009) 155-160
14. Bhattacharjee Y. Psychiatric research. Is internal timing key to mental health?. Science 317 (2007) 1488-1490
15. Bunney J.N., and Potkin S.G. Circadian abnormalities, molecular clock genes and chronobiological treatments in depression. Br. Med. Bull. 86 (2008) 23-32
16. Ebert D., and Berger M. Neurobiological similarities in antidepressant sleep deprivation and psychostimulant use: a psychostimulant theory of antidepressant sleep deprivation. Psychopharmacology (Berl.) 140 (1998) 1-10
17. Ebert D., Feistel H., Kaschka W., Barocka A., and Pirner A. Single photon emission computerized tomography assessment of cerebral dopamine D2 receptor blockade in depression before and after sleep deprivation-preliminary results. Biol. Psychiatry 35 (1994) 880-885
18. Gerner R.H., Post R.M., Gillin J.C., and Bunney Jr. W.E. Biological and behavioral effects of one night's sleep deprivation in depressed patients and normals. J. Psychiatr. Res. 15 (1979) 21-40
19. Gershon A.A., Vishne T., and Grunhaus L. Dopamine D2-like receptors and the antidepressant response. Biol. Psychiatry 61 (2007) 145-153
20. Gillin J.C., Buchsbaum M., Wu J., Clark C., and Bunney Jr. W. Sleep deprivation as a model experimental antidepressant treatment: findings from functional brain imaging. Depress. Anxiety 14 (2001) 37-49
21. Hill T., and Lewicki P. Chapter 18: general linear models. Statistics: Methods and Applications. A Comprehensive Reference for Science, Industry, and Data Mining (2006), StatSoft, Tulsa (OK) 245-276
22. Kasper S., Kick H., Voll G., and Vieira A. Therapeutic sleep deprivation and antidepressant medication in patients with major depression. Eur. Neuropsychopharmacol. 1 (1991) 107-111
23. Lachman H.M., Papolos D.F., Saito T., Yu Y.M., Szumlanski C.L., and Weinshilboum R.M. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 6 (1996) 243-250
24. Lambert G., Johansson M., Agren H., and Friberg P. Reduced brain norepinephrine and dopamine release in treatment-refractory depressive illness: evidence in support of the catecholamine hypothesis of mood disorders. Arch. Gen. Psychiatry 57 (2000) 787-793
25. Leckman J.F., Sholomskas D., Thompson W.D., Belanger A., and Weissman M.M. Best estimate of lifetime psychiatric diagnosis: A methodological study. Arch. Gen. Psychiatry 39 (1982) 879-883
26. Matussek N., Romisch P., and Ackenheil M. MHPG excretion during sleep deprivation in endogenous depression. Neuropsychobiology 3 (1977) 23-29
27. Millan M.J. Multi-target strategies for the improved treatment of depressive states: conceptual foundations and neuronal substrates, drug discovery and therapeutic application. Pharmacol. Ther. 110 (2006) 135-370
28. Muller H.U., Riemann D., Berger M., and Muller W.E. The influence of total sleep deprivation on urinary excretion of catecholamine metabolites in major depression. Acta Psychiatr. Scand. 88 (1993) 16-20
29. Nutt D.J. The role of dopamine and norepinephrine in depression and antidepressant treatment. J. Clin. Psychiatry 67 Suppl 6 (2006) 3-8
30. Plante D.T., and Winkelman J.W. Sleep disturbance in bipolar disorder: therapeutic implications. Am. J. Psychiatry 165 (2008) 830-843
31. Schumann G., Benedetti F., Voderholzer U., Kammerer N., Hemmeter U., Travers H.W., Fiebich B., Holsboer-Trachsler E., Berger M., Seifritz E., and Ebert D. Antidepressive response to sleep deprivation in unipolar depression is not associated with dopamine D3 receptor genotype. Neuropsychobiology 43 (2001) 127-130
32. Serretti A., Benedetti F., Colombo C., Lilli R., Lorenzi C., and Smeraldi E. Dopamine receptor D4 is not associated with antidepressant activity of sleep deprivation. Psychiatry Res. 89 (1999) 107-114
33. Smeraldi E., Benedetti F., Barbini B., Campori E., and Colombo C. Sustained antidepressant effect of sleep deprivation combined with pindolol in bipolar depression - a placebo-controlled trial. Neuropsychopharmacology 20 (1999) 380-385
34. Szegedi A., Rujescu D., Tadic A., Muller M.J., Kohnen R., Stassen H.H., and Dahmen N. The catechol-O-methyltransferase Val108/158Met polymorphism affects short-term treatment response to mirtazapine, but not to paroxetine in major depression. Pharmacogenomics J. 5 (2005) 49-53
35. Tsai S.J., Gau Y.T., Hong C.J., Liou Y.J., Yu Y.W., and Chen T.J. Sexually dimorphic effect of catechol-O-methyltransferase val158met polymorphism on clinical response to fluoxetine in major depressive patients. J. Affect. Disord. 113 1-2 (2009) 183-187
36. Wirz-Justice A., Benedetti F., and Terman M. Chronotherapeutics for Affective Disorders. A Clinician's Manual for Light and Wake Therapy (2009), Karger, Basel
37. Wu J.C., and Bunney W.E. The biological basis of an antidepressant response to sleep deprivation and relapse: review and hypothesis. Am. J. Psychiatr. 147 (1990) 14-21
38. Yoshida K., Higuchi H., Takahashi H., Kamata M., Sato K., Inoue K., Suzuki T., Itoh K., and Ozaki N. Influence of the tyrosine hydroxylase val81met polymorphism and catechol-O-methyltransferase val158met polymorphism on the antidepressant effect of milnacipran. Hum. Psychopharmacol. 23 (2008) 121-128